CONTRAFECT Corp (CFRXQ) Financial Statements (2024 and earlier)

Company Profile

Business Address 28 WELLS AVENUE
YONKERS, NY 10701
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:13,700,00054,300,00042,490,28724,184,14030,452,25346,853,910
Cash and cash equivalents8,907,00016,654,00015,484,89924,184,1408,320,3176,995,046
Short-term investments 4,775,00037,631,00027,005,388 22,131,93639,858,864
Other undisclosed cash, cash equivalents, and short-term investments18,00015,000    
Prepaid expense1,382,0004,439,000    
Other current assets2,642,0004,140,000    
Other undisclosed current assets(18,000)(15,000)4,164,6156,575,375988,7991,848,063
Total current assets:17,706,00062,864,00046,654,90230,759,51531,441,05248,701,973
Noncurrent Assets
Operating lease, right-of-use asset2,241,0002,544,0002,810,6323,043,826
Property, plant and equipment627,000741,000910,0751,099,9481,076,0991,093,903
Other noncurrent assets105,000613,000739,970105,420355,420393,603
Total noncurrent assets:2,973,0003,898,0004,460,6774,249,1941,431,5191,487,506
TOTAL ASSETS:20,679,00066,762,00051,115,57935,008,70932,872,57150,189,479
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:7,000,00011,517,0005,415,5769,426,0615,797,0194,420,668
Accounts payable13,671,0002,389,0001,805,8542,622,2721,427,2871,302,431
Accrued liabilities6,498,0009,128,0003,609,7226,803,7894,369,7323,118,237
Other undisclosed accounts payable and accrued liabilities(13,169,000)     
Debt    631,889  
Other undisclosed current liabilities13,840,000657,000644,527   
Total current liabilities:20,840,00012,174,0006,060,10310,057,9505,797,0194,420,668
Noncurrent Liabilities
Long-term debt and lease obligation:  2,609,0002,958,8953,264,128  
Liabilities, other than long-term debt11,691,0002,603,00029,476,8366,141,72521,533,59214,575,366
Deferred revenue and credits704,240
Deferred rent credit     679,182
Other liabilities182,00073,00072,74772,74772,747321,689
Operating lease, liability2,210,0002,609,0002,958,8953,264,128
Derivative instruments and hedges, liabilities9,299,0002,530,00029,404,0896,068,97820,781,66313,549,437
Total noncurrent liabilities:11,691,0005,212,00032,435,7319,405,85321,533,59214,575,366
Total liabilities:32,531,00017,386,00038,495,83419,463,80327,330,61118,996,034
Equity
Equity, attributable to parent(11,852,000)49,376,00012,619,74515,544,9065,541,96031,193,445
Common stock1,0004,0002,7811,5337,9417,366
Additional paid in capital313,884,000310,008,000252,907,942227,657,758204,884,211192,896,367
Accumulated other comprehensive loss (32,000)(84,000)(20,920) (30,300)(74,820)
Accumulated deficit(325,705,000)(260,552,000)(240,270,058)(212,114,385)(199,319,892)(161,635,468)
Other undisclosed equity      
Total equity:(11,852,000)49,376,00012,619,74515,544,9065,541,96031,193,445
TOTAL LIABILITIES AND EQUITY:20,679,00066,762,00051,115,57935,008,70932,872,57150,189,479

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Operating expenses(64,608,000)(47,265,000)(34,239,589)(27,866,448)(31,124,425)(26,563,757)
Operating loss:(64,608,000)(47,265,000)(34,239,589)(27,866,448)(31,124,425)(26,563,757)
Nonoperating income (expense)(545,000)26,983,0006,083,91615,071,955(6,559,999)11,046,099
Other nonoperating expense(4,813,000) (2,165,044)  (905,014)
Loss from continuing operations:(65,153,000)(20,282,000)(28,155,673)(12,794,493)(37,684,424)(15,517,658)
Loss before gain (loss) on sale of properties:(20,282,000)(28,155,673)(12,794,493)(37,684,424)(15,517,658)
Other undisclosed net income130,306,000     
Net income (loss):65,153,000(20,282,000)(28,155,673)(12,794,493)(37,684,424)(15,517,658)
Other undisclosed net loss attributable to parent(130,306,000)     
Net loss available to common stockholders, diluted:(65,153,000)(20,282,000)(28,155,673)(12,794,493)(37,684,424)(15,517,658)

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):65,153,000(20,282,000)(28,155,673)(12,794,493)(37,684,424)(15,517,658)
Comprehensive income (loss):65,153,000(20,282,000)(28,155,673)(12,794,493)(37,684,424)(15,517,658)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(130,254,000)(63,000)(20,920)30,30044,520(23,154)
Comprehensive loss, net of tax, attributable to parent:(65,101,000)(20,345,000)(28,176,593)(12,764,193)(37,639,904)(15,540,812)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: